|
|
Volumn 7, Issue 1, 2011, Pages 40-41
|
|
Safer than safe: Lipid nanoparticulate encapsulation of tacrolimus with enhanced targeting and improved safety for atopic dermatitis
a
|
|
Author keywords
Improved safety; Tacrolimus; Targeting
|
|
Indexed keywords
ADVERSE EVENTS;
ATOPIC DERMATITIS;
DIRECT CONTACT;
DRUG RELEASE;
HIGH PRESSURE HOMOGENIZATION;
IN-VIVO;
INFLAMMATORY RESPONSE;
LIPID NANOPARTICLES;
LOCAL SIDE EFFECTS;
NANO PARTICULATES;
SIGNIFICANT IMPACTS;
SKIN DISORDERS;
TACROLIMUS;
TARGETING;
DRUG PRODUCTS;
HOMOGENIZATION METHOD;
NANOPARTICLES;
LIPID NANOPARTICLE;
NANOPARTICLE;
TACROLIMUS;
UNCLASSIFIED DRUG;
IMMUNOSUPPRESSIVE AGENT;
LIPID;
NANOCAPSULE;
ANIMAL EXPERIMENT;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
ATOPIC DERMATITIS;
CONTROLLED STUDY;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MECHANISM;
DRUG RELEASE;
DRUG SAFETY;
DRUG SOLUBILITY;
DRUG TARGETING;
HOMOGENATE;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
NANOENCAPSULATION;
NONHUMAN;
RAT;
SKIN;
SKIN PERMEABILITY;
ANIMAL;
CHEMISTRY;
PATHOLOGY;
TREATMENT OUTCOME;
ANIMALS;
DERMATITIS, ATOPIC;
IMMUNOSUPPRESSIVE AGENTS;
LIPIDS;
NANOCAPSULES;
RATS;
TACROLIMUS;
TREATMENT OUTCOME;
|
|
EID: 79957765636
PISSN: 15507033
EISSN: 15507041
Source Type: Journal
DOI: 10.1166/jbn.2011.1191 Document Type: Article |
|
Times cited : (27)
|
|
References (1)
|
